1 |
Westaby, S. 1993. Aprotinin in perspective. Ann. Thorac. Surg. 55, 1033-1041
DOI
ScienceOn
|
2 |
Wippermann, C. F., F. X. Schmid and B. Eberle. 1999. Reduced inotrpic support after aprotinin therapy during pediatric cardiac operations. Ann. Thorac. Surg. 67, 173-176
DOI
ScienceOn
|
3 |
Gurevith, J., J. Barak, E. Hochhauser, Y. Paz and V. Yakirevich. 1994. Aprotinin improves myocardial recovery after ischemia and reperfusion: Effects of the drug on isolated rat hearts. J. Thorac. Cardiovasc. Surg. 108, 109-118
|
4 |
Liu, B., L. Tengborn and G. Larson. 1995. Half-dose aprotinin preserve hemostatic function in patient undergoing bypass operations. Ann. Thorac. Surg. 59, 1534-1540
DOI
ScienceOn
|
5 |
McMahon, M. J. and A. T. R. Axon. 1984. Anaphylactic reaction to aprotinin. Br. J. Med. 289, 1696
|
6 |
Royston, D., B. P. Bidstrup, K. M. Taylor and R. N. Sapsford. 1987. Effect of aprotinin on need for blood transfusion after repeat open heart surgery. Lancet 2, 1289-1291
|
7 |
Shin, Y. C., T. K. Cheon, Y. S. Won, Y. J Kim and J. R. Rho. 1996. Effect of aprotinin on postoperative bleeding and blood coagulation system in pediatric open heart surgery. Kor. J. Thorac. Cardiovasc. Surg. 29, 303-310
|
8 |
Sunamori, M., I. Sultan and A. Suzuki. 1991. Effect of aprotinin to improve myocardial viability in myocardial preservation followed by reperfusion. Ann. Thorac. Surg. 52, 971-9
DOI
ScienceOn
|
9 |
Sundt, T. M., N. T. Kouchoukos and J. E. Saffitz. 1993. Renal dysfunction and intravascular coagulation with aprotinin and hypothermic circulatory arrest. Ann. Thorac. Surg. 55, 1418-1424
DOI
ScienceOn
|
10 |
Ulker, S., P. P. Mckeown and U. Bayraktutan. 2002. Aprotinin impairs coronary endothelial function and down-regulates endothelial NOs in rat coronary microvascular endothelial cells. Cardiovascular Research 55, 830-837
DOI
ScienceOn
|
11 |
van Oeveren, W., M. P. Harder, K. J. Roozendaal, L. Eijsman and C. R. Wildevuur. 1990. Aprotinin products platelet against the initial effect of cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 99, 788-797
|
12 |
Wachtfogel, Y. T., U. Kucich and C. E. Hack. 1993. Aprotinin inhibits the contact, neutrophil and platelet activation systems, during simulated extracorporeal perfusion. J. Thorac. Cardiovasc. Surg. 106, 1-10
|
13 |
Covino, E., D. Pepino, D. Iorio, L. Marino, P. Ferrara and N. Spampinalo. 1991. Low dose aprotinin as blood saver in open heart surgery. Eur. J. Cardiothorac. Surg. 5, 619-624
|
14 |
Ashraf, S., Y. Tian and D. Cowan. 1997. 'Low-dose' aprotinin modifies hemostasis but not proinfIammatory cytokine release. Ann. Thorae. Surg. 63, 68-73
DOI
ScienceOn
|
15 |
Baufreton, C., H. Velthuis, P. G. M. Jansen, P. Lebesnerais, C. H. R. Wildevuur and D. Y. Loisance. 1996. Reduction of blood activation in patients requiring aprotinin during cardiopulmonary bypass for coronary artery surgery. ASAlO. J. 42:M, 417-423
DOI
ScienceOn
|
16 |
Boher, H., A. Bach, F. Fleicher and J. Lang. 1990. Adverse haemodynamic effects of high-dose aprotinin in a paediatric cardiac surgical patients. Anaesthesia 45, 853-854
DOI
ScienceOn
|
17 |
Defraigne, J. O., J. Pincemail, R. Larbuisson, F. Blaffart and R. Limet. 2000. Cytokine release and neutrophil activation are not prevented by heparin-coated circuits and aprotinin administration. Ann. Thorac. Surg. 69, 1084-1091
DOI
ScienceOn
|
18 |
Harder, M. P., L. Eijsman, K. J. Roozendal, W. van Oevern and C. R. Wildevuur. 1991. Aprotinin reduces intraoperative and postoperative blood loss in membrane oxygenator cardiopulmonary bypass. Ann. Thorac. Surg. 51, 936-941
DOI
ScienceOn
|
19 |
Kawasuji, M., K. Ueyama and S. Naoki. 1993. Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypass. Ann. Thorac. Surg. 55, 1205-1209
DOI
ScienceOn
|